In patients with urothelial carcinoma, combined treatment with PD-1 and CTLA-4 before tumor resection significantly increases TLS density within the tumor, indicating that TLSs are induced and recruited during treatment, activating B cells to initiate anti-tumor immune responses (190). This evidence concerns the gene CTLA4 and neoplasm.